{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:40:06Z","timestamp":1772102406463,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U1803129"],"award-info":[{"award-number":["U1803129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Research and Development Plan of Anhui Province in 2021-Population Health Project","award":["202104j07020032"],"award-info":[{"award-number":["202104j07020032"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10753-022-01774-2","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T08:02:58Z","timestamp":1673856178000},"page":"861-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-\u03baB Pathway and the Effects of CP-25"],"prefix":"10.1007","volume":"46","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa-qin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-yang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-fang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"1774_CR1","doi-asserted-by":"publisher","unstructured":"Ganesan R., M. Rasool. 2017. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. International Reviews of Immunology 36(1): 20\u201330. https:\/\/doi.org\/10.1080\/08830185.2016.1269175","DOI":"10.1080\/08830185.2016.1269175"},{"key":"1774_CR2","doi-asserted-by":"publisher","unstructured":"Zhang Q., J. Liu, M. Zhang, S. Wei, R. Li, Y. Gao, W. Peng, C. Wu. 2019. Apoptosis induction of fibroblast-like synoviocytes is an important molecular-mechanism for herbal medicine along with its active components in treating rheumatoid arthritis. Biomolecules 9(12). https:\/\/doi.org\/10.3390\/biom9120795","DOI":"10.3390\/biom9120795"},{"key":"1774_CR3","doi-asserted-by":"publisher","unstructured":"Lee J.W., J. Lee, S.H. Um, E.Y. Moon. 2017. Synovial cell death is regulated by TNF-alpha-induced expression of B-cell activating factor through an ERK-dependent increase in hypoxia-inducible factor-1alpha.\u00a0Cell Death Disease\u00a08(4): e2727. https:\/\/doi.org\/10.1038\/cddis.2017.26","DOI":"10.1038\/cddis.2017.26"},{"key":"1774_CR4","doi-asserted-by":"publisher","unstructured":"Nygaard G., G.S. Firestein. 2020. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nature Reviews Rheumatology 16(6): 316\u201333. https:\/\/doi.org\/10.1038\/s41584-020-0413-5","DOI":"10.1038\/s41584-020-0413-5"},{"key":"1774_CR5","doi-asserted-by":"publisher","unstructured":"de Oliveira P.G., M. Farinon, E. Sanchez-Lopez, S. Miyamoto, M. Guma. 2019. Fibroblast-like synoviocytes glucose metabolism as a therapeutic target in rheumatoid arthritis. Frontiers in Immunology 10:1743. https:\/\/doi.org\/10.3389\/fimmu.2019.01743","DOI":"10.3389\/fimmu.2019.01743"},{"key":"1774_CR6","doi-asserted-by":"publisher","unstructured":"Bottini N., G.S. Firestein. 2013. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors.\u00a0Nature Reviews Rheumatology\u00a09(1): 24\u201333. https:\/\/doi.org\/10.1038\/nrrheum.2012.190","DOI":"10.1038\/nrrheum.2012.190"},{"key":"1774_CR7","doi-asserted-by":"publisher","unstructured":"Sabeh F., D. Fox, S.J. Weiss. 2010. Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. Journal of Immunology 184(11): 6396\u2013406. https:\/\/doi.org\/10.4049\/jimmunol.0904068","DOI":"10.4049\/jimmunol.0904068"},{"key":"1774_CR8","doi-asserted-by":"publisher","unstructured":"Tolboom T.C., E. Pieterman, W.H. van der Laan, R.E. Toes, A.L. Huidekoper, R.G. Nelissen, F.C. Breedveld, T.W. Huizinga. 2002. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Annals of Rheumatic Diseases\u00a061(11): 975\u201380. https:\/\/doi.org\/10.1136\/ard.61.11.975","DOI":"10.1136\/ard.61.11.975"},{"key":"1774_CR9","doi-asserted-by":"publisher","unstructured":"Bartok B., G.S. Firestein. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunology Reviews 233(1): 233\u201355. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00859.x","DOI":"10.1111\/j.0105-2896.2009.00859.x"},{"key":"1774_CR10","doi-asserted-by":"publisher","unstructured":"Gowhari Shabgah A., Z. Shariati-Sarabi, J. Tavakkol-Afshari, A. Ghasemi, M. Ghoryani, M. Mohammadi. 2020. A significant decrease of BAFF, APRIL, and BAFF receptors following mesenchymal stem cell transplantation in patients with refractory rheumatoid arthritis. Gene 732:144336. https:\/\/doi.org\/10.1016\/j.gene.2020.144336","DOI":"10.1016\/j.gene.2020.144336"},{"key":"1774_CR11","doi-asserted-by":"publisher","unstructured":"Kayagaki N., M. Yan, D. Seshasayee, H. Wang, W. Lee, D.M. French, I.S. Grewal, A.G. Cochran, N.C. Gordon, J. Yin, M.A. Starovasnik, V.M. Dixit. 2002. BAFF\/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity 17(4): 515\u201324. https:\/\/doi.org\/10.1016\/s1074-7613(02)00425-9","DOI":"10.1016\/s1074-7613(02)00425-9"},{"key":"1774_CR12","doi-asserted-by":"publisher","unstructured":"Ferraccioli G., E. Gremese. 2017. B cell activating factor (BAFF) and BAFF receptors: fakes and facts. Clinical and Experimental Immunology\u00a0190(3): 291\u20132. https:\/\/doi.org\/10.1111\/cei.13039","DOI":"10.1111\/cei.13039"},{"key":"1774_CR13","doi-asserted-by":"publisher","unstructured":"Shabgah A.G., Z. Shariati-Sarabi, J. Tavakkol-Afshari, M. Mohammadi. 2019. The role of BAFF and APRIL in rheumatoid arthritis. Journal of Cellular Physiology\u00a0234(10): 17050\u201363. https:\/\/doi.org\/10.1002\/jcp.28445","DOI":"10.1002\/jcp.28445"},{"key":"1774_CR14","doi-asserted-by":"publisher","unstructured":"Morais S.A., A. Vilas-Boas, D.A. Isenberg. 2015. B-cell survival factors in autoimmune rheumatic disorders. Therapeutic Advances in Musculoskeletal Disease\u00a07(4): 122\u201351. https:\/\/doi.org\/10.1177\/1759720x15586782","DOI":"10.1177\/1759720x15586782"},{"key":"1774_CR15","doi-asserted-by":"publisher","unstructured":"Nakayamada S., Y. Tanaka. 2016. BAFF- and APRIL-targeted therapy in systemic autoimmune diseases. Inflammation and Regeneration\u00a036: 6. https:\/\/doi.org\/10.1186\/s41232-016-0015-4","DOI":"10.1186\/s41232-016-0015-4"},{"key":"1774_CR16","doi-asserted-by":"publisher","unstructured":"Samy E., S. Wax, B. Huard, H. Hess, P. Schneider. 2017. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. International Reviews of Immunology\u00a036(1): 3\u201319. https:\/\/doi.org\/10.1080\/08830185.2016.1276903","DOI":"10.1080\/08830185.2016.1276903"},{"key":"1774_CR17","doi-asserted-by":"publisher","unstructured":"Smolen J.S., M.E. Weinblatt, D. van der Heijde, W.F. Rigby, R. van Vollenhoven, C.O. Bingham, 3rd, M. Veenhuizen, A. Gill, F. Zhao, W.J. Komocsar, P.Y. Berclaz, R. Ortmann, C. Lee. 2015. Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study. Annals of Rheumatic Diseases\u00a074(8): 1567\u201370. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207090","DOI":"10.1136\/annrheumdis-2014-207090"},{"key":"1774_CR18","doi-asserted-by":"publisher","unstructured":"Distler A., L. Deloch, J. Huang, C. Dees, N.Y. Lin, K. Palumbo-Zerr, C. Beyer, A. Weidemann, O. Distler, G. Schett, J.H. Distler. 2013. Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling. Annals of Rheumatic Diseases\u00a072(9): 1575\u201380. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202275","DOI":"10.1136\/annrheumdis-2012-202275"},{"key":"1774_CR19","doi-asserted-by":"publisher","unstructured":"Yang X.Z., W. Wei. 2020. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacologica Sinica\u00a041(11): 1387\u201394. https:\/\/doi.org\/10.1038\/s41401-020-00510-6","DOI":"10.1038\/s41401-020-00510-6"},{"key":"1774_CR20","doi-asserted-by":"publisher","unstructured":"Tang H., Y.J. Wu, F. Xiao, B. Wang, J. Asenso, Y. Wang, W. Sun, C. Wang, W. Wei. 2019. Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomedicine and Pharmacotherapy\u00a0119: 109432. https:\/\/doi.org\/10.1016\/j.biopha.2019.109432","DOI":"10.1016\/j.biopha.2019.109432"},{"key":"1774_CR21","doi-asserted-by":"publisher","unstructured":"Chen J., Y. Wang, H. Wu, S. Yan, Y. Chang, W. Wei. 2018. A modified compound from Paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice. Frontiers in Pharmacology 9: 563. https:\/\/doi.org\/10.3389\/fphar.2018.00563","DOI":"10.3389\/fphar.2018.00563"},{"key":"1774_CR22","doi-asserted-by":"publisher","unstructured":"Chang Y., X. Jia, F. Wei, C. Wang, X. Sun, S. Xu, X. Yang, Y. Zhao, J. Chen, H. Wu, L. Zhang, W. Wei. 2016. CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Scientific Reports\u00a06: 26239. https:\/\/doi.org\/10.1038\/srep26239","DOI":"10.1038\/srep26239"},{"key":"1774_CR23","doi-asserted-by":"publisher","unstructured":"Zhang F., J.L. Shu, Y. Li, Y.J. Wu, X.Z. Zhang, L. Han, X.Y. Tang, C. Wang, Q.T. Wang, J.Y. Chen, Y. Chang, H.X. Wu, L.L. Zhang, W. Wei. 2017. CP-25, A novel anti-inflammatory and immunomodulatory drug, inhibits the functions of activated human B cells through regulating BAFF and TNF-alpha signaling and comparative efficacy with biological agents. Frontiers in Pharmacology 8: 933. https:\/\/doi.org\/10.3389\/fphar.2017.00933","DOI":"10.3389\/fphar.2017.00933"},{"key":"1774_CR24","doi-asserted-by":"publisher","unstructured":"Li H., A. Wan. 2013. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediators Inflammation p.\u00a0953462. https:\/\/doi.org\/10.1155\/2013\/953462","DOI":"10.1155\/2013\/953462"},{"key":"1774_CR25","doi-asserted-by":"publisher","unstructured":"Chen M., X. Lin, Y. Liu, Q. Li, Y. Deng, Z. Liu, D. Brand, Z. Guo, X. He, B. Ryffel, S.G. Zheng. 2014. The function of BAFF on T helper cells in autoimmunity. Cytokine & Growth Factor Reviews\u00a025(3): 301\u20135. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.12.011","DOI":"10.1016\/j.cytogfr.2013.12.011"},{"key":"1774_CR26","doi-asserted-by":"publisher","unstructured":"Hu S., R. Wang, M. Zhang, K. Liu, J. Tao, Y. Tai, W. Zhou, Q. Wang, W. Wei. 2019. BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway. Biomedicine & Pharmacotherapy\u00a0114: 108796. https:\/\/doi.org\/10.1016\/j.biopha.2019.108796","DOI":"10.1016\/j.biopha.2019.108796"},{"key":"1774_CR27","doi-asserted-by":"publisher","unstructured":"Smulski C.R., H. Eibel. 2018. BAFF and BAFF-receptor in B cell selection and survival. Frontiers in Immunology 9: 2285. https:\/\/doi.org\/10.3389\/fimmu.2018.02285","DOI":"10.3389\/fimmu.2018.02285"},{"key":"1774_CR28","doi-asserted-by":"publisher","unstructured":"Jia X., F. Wei, X. Sun, Y. Chang, S. Xu, X. Yang, C. Wang, W. Wei. 2016. CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4(+) T cells. Journal of Ethnopharmacology 189: 194\u2013201. https:\/\/doi.org\/10.1016\/j.jep.2016.05.034","DOI":"10.1016\/j.jep.2016.05.034"},{"key":"1774_CR29","doi-asserted-by":"publisher","unstructured":"Han C., Y. Li, Y. Zhang, Y. Wang, D. Cui, T. Luo, Y. Zhang, Q. Liu, H. Li, C. Wang, D. Xu, Y. Ma, W. Wei. 2021. Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. Acta Pharmaceutica Sinica B 11(7):\u00a01835\u201352.\u00a0https:\/\/doi.org\/10.1016\/j.apsb.2021.01.015","DOI":"10.1016\/j.apsb.2021.01.015"},{"key":"1774_CR30","doi-asserted-by":"publisher","unstructured":"Li Y., M.Y. Jiang, J.Y. Chen, Z.W. Xu, J.W. Zhang, T. Li, L.L. Zhang, W. Wei. 2021. CP-25 exerts therapeutic effects in mice with dextran sodium sulfate-induced colitis by inhibiting GRK2 translocation to downregulate the TLR4-NF-kappaB-NLRP3 inflammasome signaling pathway in macrophages. IUBMB Life 73(12): 1406\u201322.\u00a0https:\/\/doi.org\/10.1002\/iub.2564","DOI":"10.1002\/iub.2564"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01774-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-022-01774-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-022-01774-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T03:38:00Z","timestamp":1684294680000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-022-01774-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1774"],"URL":"https:\/\/doi.org\/10.1007\/s10753-022-01774-2","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"All experiments were performed according to the Ethics Review Committee of Anhui Medical University (No.2018003 and No. LLSC2018007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was given by the patients or their families.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}